Obesity

Questions discussed in this category

How should clinicians balance the use of finerenone with other heart failure treatments like SGLT2 inhibitors, considering their glycemic benefits?

Butt et al., PMID 39818225

2 Answers available

Do you routinely check vitamin K levels in post-bariatric surgery patients?

There seems to be little guidance on vitamin replacement in these patients. Vitamin K level < 50 yet PT/INR is normal. Is the vitamin K assay usefu...

1 Answer available

When managing patients with suspected MASLD, what specific criteria or findings would prompt you to refer them to hepatology?

1 Answer available

Does your approach to extubating obese patients differ from your approach in non-obese patients?

1 Answer available

Papers discussed in this category

Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 2019 Jun 05

Vitamin K-what is known regarding bariatric surgery patients: a systematic review.

Nutrients, 2016 Jan 02

Concepts and Controversies in Evaluating Vitamin K Status in Population-Based Studies.

European heart journal, 2016-07-14

A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease.

The New England journal of medicine, 2024 Sep 01

Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.

Circulation, 2024 Sep 28

Effects of the Nonsteroidal MRA Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Heart Failure.

Obesity

Questions discussed in this category

Papers discussed in this category

Related Topics